1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market - Forecasts till 2019

The internal neuromodulation market in Saudi Arabia, South Africa, and Turkey is a fast emerging market. The growth of this market is driven by factors such as public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and the increasingly aging population. However, factors such as the disadvantages of a dearth of skilled professional and the reimbursement scenario restrain the growth of this market.

The report has been broadly classified into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electric neurostimulation. The spinal cord stimulator segment is further categorized on the basis of application into chronic pain, failed back surgery syndrome, ischemic pain, and others. Likewise, the deep brain stimulation market has its application in Parkinson’s disease, tremors, depression, and others that include chronic pain, dystonia, Tourette’s syndrome, and Alzheimer’s disease.

The sacral nerve stimulation market has applications in urinary incontinence and fecal incontinence. Vagus nerve stimulator comprises epilepsy and other applications; gastric stimulation includes gastroparaeisis and others. The gastric neurostimulator market segment is estimated to grow at the highest CAGR from 2014 to 2019. The drivers for this market are the increase in the number of people who suffer from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which is a major opportunity for players in this segment.

The market is estimated to be dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Aleva Neurotherapeutics SA (U.S.) Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches & partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the internal neuromodulation market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various applications of particular modalities of the internal neuromodulation market. The in-depth industry analysis of drivers, inhibitors, and industry trends has been captured in the report. The report also presents the therapy/modality market share analysis of top players country-wise and the company profiles of major companies of the market. It comprises and discusses the rudimentary views on the competitive landscape, emerging- and high-growth segments of the internal neuromodulation market, high-growth regions & countries & their respective regulatory policies.

The report will enrich both the established firms as well as new entrants/smaller firms. It gauges the pulse of the market, which in turn will help the firms garner the larger market share and better market presence. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share/presence.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on internal neurostimulation/neuromodulation modalities offered by the top 10 players in the market

- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the internal neuromodulation market

Table Of Contents

Middle East and Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market - Forecasts till 2019
TABLE OF CONTENTS

1 INTRODUCTION 9
1.1 OBJECTIVES OF THE STUDY 9
1.2 MARKET SEGMENTATION and COVERAGE 9
1.3 STAKEHOLDERS 10
2 RESEARCH METHODOLOGY 11
2.1 INTEGRATED ECOSYSTEM OF INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET 11
2.2 ARRIVING AT THE neuromostimulation/neuromodulation MARKET SIZE 12
2.2.1 MARKET SHARE 12
2.2.2 TOP-DOWN APPROACH 12
3 EXECUTIVE SUMMARY 13
4 MARKET OVERVIEW 15
4.1 INTRODUCTION 15
4.2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET 15
4.3 MARKET DRIVERS and INHIBITORS 17
5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY 20
5.1 INTRODUCTION 20
5.2 SPINAL CORD STIMULATION 23
5.3 DEEP BRAIN STIMULATION 25
5.4 SACRAL NERVE STIMULATION 27
5.5 VAGUS NERVE STIMULATON 29
5.6 GASTRIC ELECTRICAL STIMULATION (GES) 30
6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET,BY APPLICATION 33
6.1 INTRODUCTION 33
6.1.1 SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION/ GEOGRAPHY 33
6.1.1.1 Spinal Cord Stimulation (SCS) Market, by Application 34
6.1.1.2 Spinal Cord Stimulation (SCS) Market, by Geography 37
6.1.2 DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION/ GEOGRAPHY 40
6.1.2.1 Deep Brain Stimulation (DBS) Market, by Application 41
6.1.2.2 Deep Brain Stimulation (DBS) Market, by Geography 44
6.1.3 SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION/ GEOGRAPHY 47
6.1.3.1 Sacral Nerve Stimulation (SNS) Market, by Application 48
6.1.3.2 Sacral Nerve Stimulation (SNS) Market, by Geography 51
6.1.4 VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION/GEOGRAPHY 53
6.1.4.1 Vagus Nerve Stimulation (VNS) Market, by Application 54
6.1.4.2 Vagus Nerve Stimulation (VNS) Market, by Geography 57
6.1.5 GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY APPLICATION/ GEOGRAPHY 58
6.1.5.1 Gastric Electrical Stimulation (GES) Market, by Application 59
6.1.5.2 Gastric Electrical Stimulation (GES) Market, by Geography 62
7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPETITIVE LANDSCAPE 63
7.1 Company share analysis: by Modality 63
7.1.1 SPINAL CORD STIMULATION 63
7.1.2 DEEP BRAIN STIMULATION 65
7.1.3 SACRAL NERVE STIMULATION 66
7.1.4 VAGUS NERVE STIMULATION 66
7.2 COMPANY PRESENCE IN internal neurostimulation/ neuromodulationMARKET 68
8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY COMPANY 69
8.1 BOSTON SCIENTIFIC CORPORATION (U.S.) 69
1.1.1. OVERVIEW 69
1.1.2. KEY FINANCIALS: 69
1.1.3. PRODUCT AND SERVICE OFFERINGS 70
1.1.4. RELATED DEVELOPMENTS 70
8.2 CERBOMED GMBH (GERMANY) 71
8.2.1 OVERVIEW 71
8.2.2 KEY FINANCIALS 71
8.2.3 PRODUCT AND SERVICE OFFERINGS 71
8.3 CYBERONICS, INC. (U.S.) 72
8.3.1 OVERVIEW 72
8.3.2 KEY FINANCIALS 72
8.3.3 PRODUCT AND SERVICE OFFERINGS 72
8.4 ENTEROMEDICS, INC. (U.S.) 73
8.4.1 OVERVIEW 73
8.4.2 KEY FINANCIALS 73
8.4.3 PRODUCT AND SERVICE OFFERINGS 73
8.5 MEDTRONIC, INC. (U.S.) 74
8.5.1 OVERVIEW 74
8.5.2 KEY FINANCIALS 74
8.5.3 PRODUCT AND SERVICE OFFERINGS 75
8.5.4 RELATED DEVELOPMENTS 76

8.6 ST. JUDE MEDICAL (U.S.) 77
8.6.1 OVERVIEW 77
8.6.2 KEY FINANCIALS 77
8.6.3 PRODUCT AND SERVICE OFFERINGS 78
8.6.4 RELATED DEVELOPMENTS 79
8.7 SYNAPSE BIOMEDICAL, INC. (U.S.) 80
8.7.1 OVERVIEW 80
8.7.2 KEY FINANCIALS 80
8.7.3 PRODUCT AND SERVICE OFFERINGS 80
8.8 UROPLASTY, INC. (U.S.) 81
8.8.1 OVERVIEW 81
8.8.2 KEY FINANCIALS 81
8.8.3 PRODUCT AND SERVICE OFFERINGS 81
9 APPENDIX 82
9.1 CUSTOMIZATION OPTIONS 82
9.1.1 PRODUCT ANALYSIS 82
9.1.2 EPIDEMIOLOGY DATA 82
9.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 82
9.1.4 REGULATORY FRAMEWORK 82
9.2 RELATED REPORTS 83
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 83
9.3.1 SNAPSHOTS 84





LIST OF TABLES


TABLE 1 GLOBAL INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET,

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partnering deals ...

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.